Showing 1,681 - 1,700 results of 4,481 for search '"Toxicity"', query time: 0.09s Refine Results
  1. 1681

    Melatonin in Hypoxic-Ischemic Brain Injury in Term and Preterm Babies by Justyna Paprocka, Marek Kijonka, Beata Rzepka, Maria Sokół

    Published 2019-01-01
    “…Melatonin efficacy, low toxicity, and ability to readily cross through the blood-brain barrier make it a promising molecule. …”
    Get full text
    Article
  2. 1682

    Polymer and nanocomposite fillers as advanced materials in biomedical applications by Angeline Julius, Suresh Malakondaiah, Raghu Babu Pothireddy

    Published 2025-03-01
    “…Furthermore, the clinical translation of these materials is limited by gaps in toxicity assessment, biodegradation evaluation, and comprehensive in vivo studies. …”
    Get full text
    Article
  3. 1683

    Belatacept and regulatory T cells in transplantation: synergistic strategies for immune tolerance and graft survival by Gil-Ran Kim, Kyung-Ho Nam, Je-Min Choi

    Published 2024-12-01
    “…Belatacept, a modified version of cytotoxic T lymphocyte antigen-4 immunoglobulin with increased binding affinity for its ligand, has emerged as a viable alternative to traditional CNIs due to its lower toxicity profile. Despite these benefits, belatacept is associated with a higher rate of acute rejection, which presents a challenge for long-term graft survival. …”
    Get full text
    Article
  4. 1684

    HPRNA: Predicting synergistic drug combinations for angina pectoris based on human pathway relationship network algorithm. by Mengyao Zhou, Mengfan Xu, Xiangling Zhang, Xiaochun Xing, Yang Li, Guanghui Wang, Guiying Yan

    Published 2025-01-01
    “…Over the years, synergistic drug combinations therapies have attracted widespread attention due to its advantages of overcoming drug resistance, increasing treatment efficacy and decreasing toxicity. Compared to lengthy medical drugs experimental screening, mathematical models and algorithms show great potential in synergistic drug combinations prediction. …”
    Get full text
    Article
  5. 1685

    Engineering a bacterial toxin deaminase from the DYW-family into a novel cytosine base editor for plants and mammalian cells by Dingbo Zhang, Fiona Parth, Laura Matos da Silva, Teng-Cheong Ha, Axel Schambach, Jens Boch

    Published 2025-02-01
    “…A G103S mutation in SsdA enhances C-to-T editing efficiency while reducing its toxicity. Truncations result in an extraordinarily small enzyme. …”
    Get full text
    Article
  6. 1686

    Sulfurous Gases As Biological Messengers and Toxins: Comparative Genetics of Their Metabolism in Model Organisms by Neal D. Mathew, David I. Schlipalius, Paul R. Ebert

    Published 2011-01-01
    “…As gases with potent biological activities, they are toxic as air pollutants, and the sulfurous compounds are used as fumigants. …”
    Get full text
    Article
  7. 1687

    Anticancer effects of olive oil polyphenols and their combinations with anticancer drugs by Torić Jelena, Marković Ana Karković, Brala Cvijeta Jakobušić, Barbarić Monika

    Published 2019-12-01
    “…The biggest issue concerning the chemotherapeutics is their toxicity on normal cells and persisting side effects. …”
    Get full text
    Article
  8. 1688

    The Role of Cytokines in Nephrotic Syndrome by Elham Ahmadian, Yalda Rahbar Saadat, Elaheh Dalir Abdolahinia, Milad Bastami, Mohammadali M. Shoja, Sepideh Zununi Vahed, Mohammadreza Ardalan

    Published 2022-01-01
    “…Thus, the introduction of distinctive cytokines as novel biomarkers of SRNS enables both preventions of drug-related toxicity and earlier switch to more effective therapies. …”
    Get full text
    Article
  9. 1689

    Anti-Retroviral Strategies for AIDS and Related Diseases by Mark A Wainberg, Andre Dascal, Jack Mendelson

    Published 1991-01-01
    “…Although AZT therapy has been reasonably successful, it has not been free from toxicity. In addition, there have been several reports of isolation of AZT-resistant variants of HIV-1.…”
    Get full text
    Article
  10. 1690

    Harnessing nanotechnology for enhanced epilepsy management by V. Manasa, J. Joysa Ruby, Himadri Priya Gogoi, S. Vignesh, P. H. Anjaneya, Akhil

    Published 2024-12-01
    “…Nanocarrier systems—such as nanoparticles, micelles, and liposomes—enhance drug specificity for brain delivery, improving the therapeutic efficacy and reducing off-target toxicity. New developments in nanocarrier systems for AEDs, including phenytoin, phenobarbital, carbamazepine, and valproate, demonstrate increased brain penetration, solubility, and controlled drug release, offering promising benefits in epilepsy management. …”
    Get full text
    Article
  11. 1691

    Synthesis of Pure Micro- and Nanopyrite and Their Application for As (III) Removal from Aqueous Solution by Guobao Chen, Zhangfu Zhu, Yong Qin

    Published 2016-01-01
    “…Arsenic is one of the materials that has a worldwide concern because of its high toxicity and chronic effects on human health. The existence of arsenic as As (III) is about 56 times poisonous as As (V) and more difficult to process. …”
    Get full text
    Article
  12. 1692

    Nanomaterials based biosensors applied for detection of aflatoxin B1 in cereals: a review by Loyce Namanya, Emma Panzi Mukhokosi, Ediriisa Mugampoza

    Published 2025-01-01
    “…It causes immune-suppressive effects, raising the risk of mutagenicity, carcinogenicity, teratogenicity, hepatotoxicity, and embryonic toxicity, as well as increasing illness and death. …”
    Get full text
    Article
  13. 1693

    Carboxylic Acid Bioisosteres in Medicinal Chemistry: Synthesis and Properties by Kato Bredael, Silke Geurs, Dorien Clarisse, Karolien De Bosscher, Matthias D’hooghe

    Published 2022-01-01
    “…Despite its common use as a key functionality in drugs, its presence in a lead molecule is often associated with poor pharmacokinetic properties and toxicity. In this literature overview, we discuss how the shortcomings of a carboxylic acid can be circumvented by replacing this functionality with bioisosteres. …”
    Get full text
    Article
  14. 1694

    AM3, an Oral BRM: Protective Agent against Iatrogenic Bone-Marrow and Liver Damage in Breast Cancer Patients under Conventional Adjuvant Radiochemotherapy by Vicente G Villarrubia, Paula Marquez, Jose Cobo, Guillermo J Sada

    Published 1992-01-01
    “…Besides these hematological effects, AM3 palliated subclinical hepatic toxicity due to combined radio-chemotherapy. Finally, studies on acute-phase reactants, such as C-reactive protein, IgA. and factors B, C'3, and C'5 of the complement system, suggest that a modulation of hepatic inflammatory responses by AM3 appears to be essential for clinical effects described.…”
    Get full text
    Article
  15. 1695

    NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment by Antonio Pierini, Maite Alvarez, Robert S. Negrin

    Published 2016-01-01
    “…The intensive conditioning regimens used to allow for donor hematopoietic stem cell (HSC) engraftment are often associated with severe toxicity, delayed immune reconstitution, life-threatening infections, and thus higher relapse rates. …”
    Get full text
    Article
  16. 1696

    Comparative Study On Effectiveness Of Citrus Limon Peelings And Cymbopogon Citratus Leaves Powder On Termites, Isoptera Rhinotimitidae. by Abeneitwe, Joshua

    Published 2024
    “…However, their use raised new issues, such as environmental degradation, toxicity to animals and humans, and adverse impacts on the quality of yields. …”
    Get full text
    Thesis
  17. 1697
  18. 1698

    Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15 by Xin Xu, Shantan Reddy, Saleh Bhar, Frederic D Bushman, Amy N Courtney, Gabriel A Barragán, Gengwen Tian, Erica J Di Pierro, Leonid S Metelitsa, Antonino Montalbano, Hangjin Yu, Claudia Martinez Amador, Nisha Ghatwai, Michael S Wood, Deborah Schady, Aoife M Roche, David de la Cerda, Donald Williams Parsons, Andras Heczey

    Published 2025-01-01
    “…The ability of immune cells to expand numerically after infusion distinguishes adoptive immunotherapies from traditional drugs, providing unique therapeutic advantages as well as the potential for unmanageable toxicities. Here, we describe a case of lethal hyperleukocytosis in a patient with neuroblastoma treated on phase 1 clinical trial (NCT03294954) with autologous natural killer T cells (NKTs) expressing a GD2-specific chimeric antigen receptor and cytokine interleukin 15 (GD2-CAR.15). …”
    Get full text
    Article
  19. 1699

    Chemoimmunotherapy as induction treatment in concurrent chemoradiotherapy for patients with nasopharyngeal carcinoma stage IVa by Kun-Peng Wu, Qing-Qing Li, Xu-Qiang Luo, Xiao-Xi Wang, Yan-Zhen Lai, Dan Tian, Hong-cheng Yang, Xue-Ling Wei, Lan-Ying Wang, Qiu-Ming Li, Dao Zhu, Si-Jie Chen, Yang-Si Li

    Published 2025-12-01
    “…This study aimed to evaluate the efficacy, toxicity, and survival outcomes of induction chemoimmunotherapy in patients with locoregionally advanced NPC.Methods This study analyzed 50 patients with stage IVa NPC between January 2020 and December 2023 in our hospital. …”
    Get full text
    Article
  20. 1700

    Deep learning-based synthetic CT for dosimetric monitoring of combined conventional radiotherapy and lattice boost in large lung tumors by Hongwei Zeng, Xiangyu E, Minghe Lv, Su Zeng, Yue Feng, Wenhao Shen, Wenhui Guan, Yang Zhang, Ruping Zhao, Jingping Yu

    Published 2025-01-01
    “…Abstract Purpose Conventional radiotherapy (CRT) has limited local control and poses a high risk of severe toxicity in large lung tumors. This study aimed to develop an integrated treatment plan that combines CRT with lattice boost radiotherapy (LRT) and monitors its dosimetric characteristics. …”
    Get full text
    Article